Biotron Limited Banner Image

Biotron Limited

  • Ticker BIT
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Biotron Limited Logo Image
  • 51-200 Employees
  • Based in Sydney, Australia
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. The company also develops a portfolio of preclinical antiviral drugs. Biotron Limited was incorporatedMore in 1999 and is headquartered in Sydney, Australia.
Biotron Limited

Most Recent Annual Report

Biotron Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports